✦ LIBER ✦

Cholecystokinin-octapeptide in chronic schizophrenia: A double-blind placebo-controlled study

✍ Scribed by Nair, N.P.V.; Bloom, D.M.; Debonnel, G.; Schwartz, G.; Mosticyan, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double blind controlled trials of cholec

✍ E. Peselow; B. Angrist; A. Sudilovsky; J. Corwin; J. Siekierski; F. Trent; J. Ro 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 475 KB

Treatment of chronic schizophrenia with

✍ Henry Silver; Michael Blacker; Malcolm P.I. Weller; Bernard Lerer 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Citalopram as an adjuvant in chronic sch

✍ R. K. R. Salokangas; S. Saarijärvi; T. Taiminen; H. Kallioniemi; H. Lehto; H. Ni 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

Ondansetron. A double blind placebo cont

✍ McBain, S.L.; Dineen, M.; Weller, M.; Taylor, S.; Cooksey, P.; Williams, P.; Cor 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A negative, double-blind, placebo-contro

✍ Jack A. Grebb; Richard C. Shelton; Edward H. Taylor; Llewellyn B. Bigelow 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Zotepine in the prevention of recurrence

✍ S.J. Cooper; A. Butler; J. Tweed; C. Welch; J. Raniwalla 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 196 KB